Data / Drug companies / gamma-Aminobutyric Acid A Receptor Positive Modulator
gamma-Aminobutyric Acid A Receptor Positive Modulator drugs: 2 drugs from 33 companies in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
gamma-Aminobutyric Acid A Receptor Positive Modulator is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 111 products in this class from 33 companies, covering 2 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on June 23, 2026.
The request: Get every company that lists a gamma-Aminobutyric Acid A Receptor Positive Modulator drug in the FDA NDC directory, with headquarters, website and size. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 33Companies
- 111Products
- 2Drugs by generic name
Drugs in the gamma-Aminobutyric Acid A Receptor Positive Modulator class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Zolpidem tartrate | 109 | 38 |
| Zolpidem tartrate sublingual | 2 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Advanced Rx of Tennessee, LLC | 10 | tablet; tablet, film coated | Generic drugs (ANDA) | April 15, 2025 |
| Bryant Ranch Prepack | 8 | tablet; tablet, extended release | Generic drugs (ANDA) | September 24, 2020 |
| NuCare Pharmaceuticals,Inc. | 8 | tablet; tablet, extended release | Generic drugs (ANDA) | April 11, 2014 |
| A-S Medication Solutions | 7 | tablet, film coated; tablet | Generic drugs (ANDA) | September 5, 2007 |
| Aphena Pharma Solutions - Tennessee, LLC | 7 | tablet; tablet, extended release | Generic drugs (ANDA) | May 15, 2017 |
| Bryant Ranch Prepack | 7 | tablet, extended release; tablet | Generic drugs (ANDA) | September 24, 2020 |
| Asclemed USA, Inc. | 6 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | April 11, 2014 |
| Preferred Pharmaceuticals Inc. | 6 | tablet, extended release; tablet | Generic drugs (ANDA) | April 11, 2025 |
| Cosette Pharmaceuticals, Inc. | 4 | tablet, film coated; tablet, coated | New drug applications (NDA) | February 7, 2025 |
| Golden State Medical Supply, Inc. | 4 | tablet, coated; tablet, film coated | New drug applications (NDA) | April 23, 2007 |
| Sandoz Inc | 4 | tablet, coated; tablet, extended release | Generic drugs (ANDA) | October 31, 2011 |
| St. Mary's Medical Park Pharmacy | 4 | tablet; tablet, coated | Generic drugs (ANDA) | August 28, 2024 |
| Remedyrepack Inc. | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | December 8, 2023 |
| Torrent Pharmaceuticals Limited | 3 | tablet; capsule | Generic drugs (ANDA) | June 23, 2026 |
| Breckenridge Pharmaceutical, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | May 18, 2026 |
| Bryant Ranch Prepack | 2 | tablet, film coated, extended release; tablet | Generic drugs (ANDA) | September 24, 2020 |
| Chartwell RX, LLC | 2 | tablet | Generic drugs (ANDA) | August 27, 2024 |
| Direct RX | 2 | tablet | Generic drugs (ANDA) | August 19, 2019 |
| Lupin Pharmaceuticals, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | April 11, 2014 |
| Northwind Health Company, LLC | 2 | tablet, coated; tablet | Generic drugs (ANDA) | May 20, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | May 4, 2007 |
| Par Health USA, LLC | 2 | tablet | Generic drugs (ANDA) | September 11, 2017 |
| Proficient Rx LP | 2 | tablet, coated | Generic drugs (ANDA) | April 23, 2007 |
| The Acme Laboratories Ltd. | 2 | tablet, film coated | Generic drugs (ANDA) | September 24, 2020 |
| Viatris Specialty LLC | 2 | tablet | New drug applications (NDA) | July 24, 2009 |
| Almatica Pharma LLC | 1 | capsule | New drug applications (NDA) | May 9, 2023 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | September 1, 2024 |
| Calvin Scott & Co., Inc. | 1 | tablet | Generic drugs (ANDA) | September 5, 2007 |
| Cardinal Health 107, LLC | 1 | tablet | Generic drugs (ANDA) | September 5, 2007 |
| Direct_Rx | 1 | tablet, extended release | Generic drugs (ANDA) | June 4, 2021 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | September 5, 2007 |
| Quality Care Products, LLC | 1 | tablet | Generic drugs (ANDA) | September 5, 2007 |
| Umedica Laboratories USA Inc. | 1 | capsule | Generic drugs (ANDA) | May 14, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 46 | 41.4% |
| Tablet, film coated | 23 | 20.7% |
| Tablet, extended release | 20 | 18% |
| Tablet, coated | 15 | 13.5% |
| Tablet, film coated, extended release | 4 | 3.6% |
| Capsule | 3 | 2.7% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.